Physician profile
Michael J Davidson
NPI 1316901499
$7,547.45
in general payments reported to CMS, 2019-2025
18 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $347 · 2021: $704 · 2022: $1,518 · 2023: $857 · 2024: $1,617 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,150 · Entertainment: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,149.71 |
| Entertainment | $600.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,022.22 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,442.98 | 2019-2021 | |
| Alcon Vision LLC | $840.01 | 2019-2024 | Clareon |
| Optos, INC. | $600.51 | 2024-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $504.31 | 2019-2024 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $476.41 | 2019-2025 | |
| Biotissue Holdings INC. | $385.70 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $372.38 | 2024-2025 | Xdemvy |
| Abbvie INC. | $299.70 | 2022 | |
| Sight Sciences, INC. | $112.00 | 2022 | |
| Maculogix, INC. | $102.91 | 2020 | |
| Sun Pharmaceutical Industries INC. | $98.24 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $69.29 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $67.66 | 2023 | |
| Dompe US, INC. | $63.13 | 2024-2025 | Oxervate |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $41.42 | 2024-2025 | Iyuzeh |
| Abb Con-Cise Optical Group LLC | $30.00 | 2024 | Spectacle Lenses, Contact Lens |
| Kala Pharmaceuticals, INC. | $18.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.